JOHN COHEN

Patient centered reforms of the Pharmacy Benefit Manager industry and Most Favored Nation policies

Patient centered reforms of the Pharmacy Benefit Manager industry and Most Favored Nation policies

Patient centered reforms of the Pharmacy Benefit Manager industry and the Inflation Reduction Act

Patient centered reforms of the Pharmacy Benefit Manager industry, concerns with the Inflation Reduction Act

Patient centered reforms of the Pharmacy Benefit Manager industry, concerns with the Inflation Reduction Act

Patient centered reforms of the Pharmacy Benefit Manager industry, concerns with the Inflation Reduction Act

Patient centered reforms of the Pharmacy Benefit Manager industry, Concerns with the Inflation Reduction Act

Patient centered reforms of the Pharmacy Benefit Manager industry, Concerns with the Inflation Reduction Act

Patient centered reforms of the Pharmacy Benefit Manager industry

PDUFA reauthorization

Advocacy to protect patient access

PDUFA reauthorization

Advocacy to protect patient access

HR3 Lower Drug Cost legislation, advocacy to protect patient access

HR3 Lower Drug Cost legislation, advocacy to protect patient access

HR3 Lower Drug Cost legislation, advocacy to protect patient access

Prescription drug coverage, biopharma innovation

HR3 Lower Drug Costs Now Act

Maintain coverage of Medicare's Six Protected Classes

Most Favored Nation/International Pricing Index

Most Favored Nation/International Pricing Index

Notice of Benefit and Payment Parameters

Rebate Reform, International Pricing Index

Rebate Reform, International Pricing Index

USMCA

Rebate Reform, International Pricing Index

Rebate Reform, International Pricing Index

6 Protected Classes and Rebate Reform

Medicare Part D, Medicare Part B

Medicare Part D

Medicare Part B, Medicare Part D

Independent Payment Advisory Board, Centers for Medicare & Medicaid Services, Children's Health Insurance Program

Independent Payment Advisory Board, Centers for Medicare & Medicaid Services

Independent Payment Advisory Board, Centers for Medicare & Medicaid Services, Part D Low Income Subsidy

Re-authorization of the Prescription Drug User Fee Act